Vineet Laboratories Ltd
NSE:VINEETLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 5-Year Average (17.3), the stock would be worth ₹-91.22 (337% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.3 | ₹38.55 |
0%
|
| 5-Year Average | 17.3 | ₹-91.22 |
-337%
|
| Industry Average | 30.4 | ₹-159.83 |
-515%
|
| Country Average | 28.7 | ₹-151.14 |
-492%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| IN |
|
Vineet Laboratories Ltd
NSE:VINEETLAB
|
740.5m INR | -7.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
804.2B USD | 42.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.4B USD | 26.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.3B GBP | 28 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
274.6B USD | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF | 20.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 11.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
149.3B USD | 19.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.9B USD | 17.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 18.9 |
| Median | 28.7 |
| 70th Percentile | 44.4 |
| Max | 877 228.1 |
Other Multiples
Vineet Laboratories Ltd
Glance View
Vineet Laboratories Ltd. specializes in pharmaceutical intermediates and fine chemicals. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-06-15. The firm is specialized in manufacturing pharmaceutical intermediates and fine chemicals. The firm is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium, Isopropyl-beta-D-thiogalactopyranoside (IPTG), 4-Nitrophenyl phosphate disodium salt (PNPP), 4-Chlorobutyryl chloride, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, n-Butylnitrite, Ethyldiazo acetate, Phenylboronic acid, Dimethyl phenoxy acetyl chloride and Piroctone Olamine.
